Retatrutide is a newly developed drug that acts as a strong GLP-1 receptor activator. This breakthrough treatment holds significant potential for controlling type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide enhances insulin secretion and limits glucagon release, leading to improved glucose control. Clinical trials have demo… Read More